Write in a clean editor, then format for Frontiers in Drug Delivery in one click — DocuGuru applies the official Frontiers template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Drug Delivery is a peer-reviewed journal published by Frontiers, covering Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems, Inhalation and Respiratory Drug Delivery. Over its lifetime it has published 124 papers, which have received 1,229 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Frontiers in Drug Delivery, 12(3), pp. 45–58.
Formats any DOI in Frontiers in Drug Delivery style. No sign-up. |
| Publishes research in | Nanoparticle-Based Drug Delivery Advanced Drug Delivery Systems Inhalation and Respiratory Drug Delivery RNA Interference and Gene Delivery Barrier Structure and Function Studies |
| ISSN | 2674-0850 |
| Citation impact (2-yr) | 5.94 |
| h-index | 18 |
| i10-index | 35 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of Copenhagen |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The delivery of therapeutics into the brain is highly limited by the blood-brain barrier (BBB). Although this is essential to protect the brain from potentially harmful material found in the blood, it poses a great challenge for the treatment of diseases affecting the central nervous system (CNS). Substances from the periphery that are required for…
Poorly water-soluble drugs demonstrate significant challenge in pharmaceutical development, which is linked to their limited oral bioavailability and therapeutic efficacy. To overcome these limitations, lipid-based formulations have emerged as a promising approach to enhance the delivery of such drugs. Moreover, encapsulation within capsules to provide a convenient dosage form for oral administration. The encapsulation techniques…
Recent advances in topical and transdermal drug delivery systems have enabled targeted delivery of therapeutics to the site of action by enhancing drug permeation across the stratum corneum and increased bioavailability. Despite various technological advancements, some dermatoses still have limited treatment options due to potential adverse effects and challenges in formulation development. To address some…
Nearly a half-century after original liposome discovery as a prospective lipid pharmaceutical carrier, the global liposomal drug delivery market has increased dramatically, with an annual market growth rate of 13.2%, valued at ∼$6,993 million by 2027. As an intrinsically complex delivery system, liposomal formulations face much greater characterization and regulatory review challenges than traditional small…
Therapeutic antibody drug development is a rapidly growing sector of the pharmaceutical industry. However, antibody drug development for the brain is a technical challenge, and therapeutic antibodies for the central nervous system account for ~3% of all such agents. The principal obstacle to antibody drug development for brain or spinal cord is the lack of…
